ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$4.82 USD
-0.67 (-12.20%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $4.96 +0.14 (2.90%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, ImmunityBio (IBRX) reported earnings of -$0.19 per share, missing the Zacks Consensus Estimate of -$0.18 per share. This reflects a negative earnings surprise of 5.56%. Look out for IBRX's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 40.74%.
Earnings History
Price & Consensus
Zacks News for IBRX
ImmunityBio (IBRX)'s Technical Outlook is Bright After Key Golden Cross
IBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services